A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence-Reference-Cited by-同舟云学术

A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence

Published:2023-07 Issue:7 Volume:4 Page:101113
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Rwandamuriye Francois Xavier^ORCID,Evans Cameron W.,Wylie Ben,Norret Marck,Vitali Breana,Ho Diwei,Nguyen Dat,Roper Ellise A.,Wang Tao,Hepburn Matt S.,Sanderson Rowan W.,Pfirrmann Maren,Fear Vanessa S.,Forbes Catherine A.,Wyatt Ken,Ryan Anne L.,Johns Terrance G.,Phillips Marianne B.,Hodder Rupert,Leslie Connull,Kennedy Brendan F.,Zemek Rachael M.,Iyer Killugudi Swaminathan,Lesterhuis Willem Joost

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference69 articles.

1. The evolution of cancer surgery and future perspectives;Wyld;Nat. Rev. Clin. Oncol.,2015

2. Local cancer recurrence: The realities, challenges, and opportunities for new therapies;Mahvi;CA A Cancer J. Clin.,2018

3. Adjuvant pembrolizumab versus placebo in resected stage iii melanoma;Eggermont;N. Engl. J. Med.,2018

4. Neoadjuvant pd-1 blockade in resectable lung cancer;Forde;N. Engl. J. Med.,2018

5. Neoadjuvant anti-pd-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma;Cloughesy;Nat. Med.,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A thermoresponsive chitosan-based in situ gel formulation incorporated with 5-FU loaded nanoerythrosomes for fibrosarcoma local chemotherapy;International Journal of Biological Macromolecules;2024-10

2. Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade;OncoImmunology;2024-08-22

3. Enhancing myocardial infarction treatment through bionic hydrogel-mediated spatial combination therapy via mtDNA-STING crosstalk modulation;Journal of Controlled Release;2024-07

4. Immunotherapies for locally aggressive cancers;Advanced Drug Delivery Reviews;2024-07

5. Exploiting temporal aspects of cancer immunotherapy;Nature Reviews Cancer;2024-06-17